Clarity Pharmaceuticals Ltd (CU6.AX)

ASX - ASX Delayed price. Currency in AUD

Add to watchlist

5.36

+0.21

(+4.08%)

At close: 04:10PM AEST

Insider roster

Individual or entity	Most-recent transaction	Date	Shares owned as of transaction date
Biggin (Colin David) Chief Executive Officer	Exercise	01 July 2022	819,100
O'Bryan-Tear (Charles Gillies) Director (Non-Executive)	Purchase	22 June 2022	120,000
Ramdahl (Thomas Ph.D.) Director (Non-Executive)	Purchase	31 May 2022	120,000
Thomas (Robert Bain) Director (Non-Executive)	Purchase	26 May 2022	1,125,000
*Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.